Jan 11, 2021 / NTS GMT
Thomas Hoffman - Solebury Trout - Analyst
Welcome to 2021 Solebury Trout Access Management Event. Our next presentation comes from Exicure. Presenting for the company will be the CEO,
Our next presentation comes from Exicure. Presenting for the Company will be the CEO, David. Please go ahead.
David Giljohann - Exicure, Inc. - CEO, Interim Principal Financial Officer, Corporate Secretary, & Director
Thanks, Thomas. Hi, everybody, and thanks for joining today. My name is David Giljohann. I'm the CEO of Exicure. And on behalf of the entire Exicure team, I'm happy to welcome you here today to hear about our company and our promise for the future of medicine.
On this version of the deck labelled January 7, we will make forward-looking statements. And we are publicly listed companies, so I refer you to our SEC guidance.
So a little bit about Exicure. We have a platform technology called spherical nucleic acid or SNA that we'll talk about today, which leads to better uptake and greater stability of nucleic acid medicines. We've demonstrated
Exicure Inc at Solebury Trout Virtual Management Access Event Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot